Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CAPN1 | P07384 | 2/20 | 0.74 |
| ▸ | CTSK | P43235 | 8/20 | 0.64 |
| ▸ | CTSL | P07711 | 9/20 | 0.62 |
| ▸ | HTRA1 | Q92743 | 1/20 | 0.62 |
| ▸ | CTSB | P07858 | 6/20 | 0.61 |
| ▸ | CTSS | P25774 | 2/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7164724 | 0.95 | CTSK (0.67) | CAPN1CTSKCTSLCTSBCTSS | |
| SCHEMBL7165055 | 0.90 | CTSK (0.66) | CAPN1CTSKCTSLCTSBCTSS | |
| SCHEMBL3044116 | 0.89 | TACR1 (0.60) | CAPN1CTSKCTSLCTSBCTSS | |
| SCHEMBL7325031 | 0.87 | CAPN1 (0.70) | CAPN1CTSKCTSLHTRA1CTSB | |
| SCHEMBL7327426 | 0.87 | CAPN1 (0.78) | CAPN1CTSKCTSLHTRA1CTSB | |
| SCHEMBL27809377 | 0.87 | CAPN1 (0.78) | CAPN1CTSKCTSLHTRA1CTSB | |
| SCHEMBL9828791 | 0.87 | CAPN1 (0.78) | CAPN1CTSKCTSLHTRA1CTSB | |
| SCHEMBL6825051 | 0.86 | REN (0.64) | CAPN1CTSKCTSLCTSBCTSS | |
| SCHEMBL8407401 | 0.86 | CTSK (0.65) | CAPN1CTSKCTSLCTSBCTSS | |
| SCHEMBL9393894 | 0.86 | CAPN1 (0.69) | CAPN1CTSKCTSLHTRA1CTSB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1389624-A1 | Phosphorous-containing cysteine and serine protease inhibitors | CEPHALON, INC. (US) | 2004-02-18 | — | — | EP | disclosed |
| EP-0871454-B1 | PHOSPHOROUS-CONTAINING CYSTEINE AND SERINE PROTEASE INHIBITORS | CEPHALON INC (US) | 2003-11-12 | — | — | EP | disclosed |
| EP-0871454-A4 | — | — | 1998-11-25 | — | — | EP | disclosed |
| EP-0871454-A1 | PHOSPHOROUS-CONTAINING CYSTEINE AND SERINE PROTEASE INHIBITORS | CEPHALON, INC. (US) | 1998-10-21 | — | — | EP | disclosed |
| US-5639732-A | FOR TREATING NERVOUS SYSTEM DISORDERS OR AS ANTIINFLAMMATORY AGENT | CEPHALON, INC. (US) | 1997-06-17 | — | — | US | disclosed |
| WO-1997003679-A1 | PHOSPHOROUS-CONTAINING CYSTEINE AND SERINE PROTEASE INHIBITORS | CEPHALON, INC. (US) | 1997-02-06 | — | — | WO | disclosed |